OrthoPediatrics (KIDS) received FDA approval for the 3P Pediatric Plating Platform Small-Mini System, the second of several systems in the 3P family, the company announced.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics announces FDA approval of 3P Pediatric Plating Platform
- OrthoPediatrics reports Q3 EPS (24c), consensus (26c)
- KIDS Upcoming Earnings Report: What to Expect?
- OrthoPediatrics price target lowered to $34 from $37 at Lake Street
- OrthoPediatrics price target lowered to $18 from $22 at Truist
